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Abstract
During X chromosome inactivation (XCI), in female placental
mammals, gene silencing is initiated by the Xist long non-coding
RNA. Xist accumulation at the X leads to enrichment of specific chro-
matin marks, including PRC2-dependent H3K27me3 and SETD8-
dependent H4K20me1. However, the dynamics of this process in
relation to Xist RNA accumulation remains unknown as is the
involvement of H4K20me1 in initiating gene silencing. To follow XCI
dynamics in living cells, we developed a genetically encoded,
H3K27me3-specific intracellular antibody or H3K27me3-mintbody.
By combining live-cell imaging of H3K27me3, H4K20me1, the X chro-
mosome and Xist RNA, with ChIP-seq analysis we uncover concurrent
accumulation of both marks during XCI, albeit with distinct genomic
distributions. Furthermore, using a Xist B and C repeat mutant,
which still shows gene silencing on the X but not H3K27me3 deposi-
tion, we also find a complete lack of H4K20me1 enrichment. This
demonstrates that H4K20me1 is dispensable for the initiation of
gene silencing, although it may have a role in the chromatin
compaction that characterises facultative heterochromatin.
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Introduction
Dynamic changes to the chromatin landscape allow for timely
execution of developmental and differentiation programmes.
Indeed, chromatin modifiers often reinforce signalling cues to initi-
ate and/or maintain an exact transcriptional outcome (Stasevich
et al, 2014; Zylicz et al, 2015; Jambhekar et al, 2019). One powerful
model, where such regulation takes place, is X chromosome inacti-
vation (XCI) in female mammals. Although much is known about
the involvement of certain chromatin marks in initiating XCI (re-
viewed in Zylicz & Heard, 2020), it was thus far impossible to track
chromatin rearrangements and the inactive X chromosome (Xi) in
living cells. What is more, the role and dynamics of some histone
modifications during XCI remains enigmatic.
In eutherian female mammals, XCI is initiated at around the time
of implantation, when each cell randomly inactivates one of the two
X chromosomes (Lyon, 1962). This process can be modelled in vitro
by differentiating female mouse embryonic stem cells (ESC) (Rastan
& Robertson, 1985). Both in vivo and in vitro, XCI depends on the
coating of the Xi by a long non-coding RNA called Xist (X-inactive-
specific transcript) (Penny et al, 1996). Xist RNA accumulation
along the Xi induces not only the silencing of over a 1,000 genes but
also a cascade of chromatin alterations (reviewed in Zylicz & Heard,
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2020). Xist is a modular non-coding RNA with specific regions play-
ing distinct roles. Its 50 A-repeat region is vital for the induction of
gene silencing (Wutz et al, 2002). It does so by recruiting SPEN, a
key RNA-binding protein, which integrates many repressive
complexes including NCOR/SMRT and HDAC3 (McHugh et al,
2015; Zylicz et al, 2019; Dossin et al, 2020). On the other hand, the
B and to a lesser extent C repeat regions are vital for the recruitment
of Polycomb-group repressive complexes (PRC) (Bousard et al,
2019; Colognori et al, 2019; Nesterova et al, 2019). Indeed, upon
Xist RNA coating Xi becomes rapidly enriched with the PRC1-depen-
dent H2AK119Ub and only subsequently with PRC2-dependent
H3K27me3 (Plath et al, 2003; Silva et al, 2003; de Napoles et al,
2004; Zylicz et al, 2019). Recent data indicate that the B and C
repeat region of Xist RNA directly recruits hnRNPK, which in turn
binds non-canonical PRC1 allowing for rapid H2AK119Ub deposi-
tion (Almeida et al, 2017; Pintacuda et al, 2017; Bousard et al, 2019;
Colognori et al, 2019). H2AK119Ub could potentially be recognised
by PRC2 cofactors allowing for de novo deposition of H3K27me3
(Blackledge et al, 2014). Importantly, Polycomb accumulation is
dispensable for the initiation of gene silencing, as Xist mutants lack-
ing the B and C repeat region can still induce XCI albeit with slightly
lower efficiency (Bousard et al, 2019; Nesterova et al, 2019).
Instead, PRC2 enables stable maintenance of the repressed state,
particularly in the context of extra-embryonic lineages (Kalantry
et al, 2006). The dynamics of accumulation of PcG marks have been
studied using ChIP-seq, although it remains unclear how precisely
this correlates with Xist RNA coating of the Xi. Indeed, the time that
lapses between Xist RNA upregulation and H3K27me3 deposition is
not known. Nor how this relates to other repressive histone marks.
Another modification that rapidly accumulates on the Xi is
H4K20me1 (Kohlmaier et al, 2004), although its role in XCI is not
well understood. H4K20me1 is deposited by SETD8 (also called Pr-
Set7) (Nishioka et al, 2002) and is thought to regulate a variety of
processes relating to transcription, chromosome condensation, DNA
replication and the DNA damage response (reviewed in van Nuland
& Gozani, 2016). Consistent with the involvement of H4K20me1 in
cell division, it transiently accumulates during G2 and mitosis,
whereas H4K20me2 and -me3 do not show similar fluctuations
during the cell cycle (Wu et al, 2010). This dynamics is achieved by
stable expression of SETD8 during G2/M when its phosphorylation
prevents the interaction with the anaphase-promoting complex
(APC). During late mitosis, CDC14 dephosphorylates SETD8 thus
stimulating its degradation by APC. On the other hand, PHF8,
H4K20me1 demethylase, is degraded by APC during early G2 (Lim
et al, 2013) together allowing for efficient deposition of H4K20me1
and successful progression through mitosis. Furthermore,
H4K20me1 accumulates at centromeres where it promotes kineto-
chore assembly and thus correct chromosome segregation (Hori
et al, 2014). The regulation of H4K20me1 levels could also be
achieved by modulating the efficiency of further methylation by
SUV420H1/2 or demethylating H4K20me2/3 by specific enzymes.
DPY-21 mediates the latter a reaction in Caenorhabditis elegans, and
its two mouse orthologs (RSBN1/RSBN1L) retain specific demethy-
lase activity in vitro (Brejc et al, 2017). However, the biological func-
tion of these enzymes remains unknown. The study of H4K20me1
during XCI has been hampered by the fact that SETD8 is absolutely
required for the progression through mitosis and embryos lacking it
die before the onset of XCI (Oda et al, 2009; Shikata et al, 2020).
While the genomic distribution of H4K20me1 at a stably inactivated
X was previously described (Calabrese et al, 2012), the dynamics of
H4K20me1 accumulation during XCI initiation in relation to Xist
RNA and H3K27me3 deposition remains unclear. Furthermore, the
precise distribution of first H4K20me1 enrichment along the X and
the molecular mechanisms underlying its dynamic accumulation on
the Xi have not previously been investigated.
To address these questions, it is important to follow the spatio-
temporal dynamics of histone modifications as they accumulate on
the X chromosome in living cells. To this end, we have previously
developed genetically encoded, modification-specific intracellular
antibodies or mintbodies, by fusing a single-chain variable fragment
(scFv) of the specific antibody with a fluorescent protein (Sato et al,
2013; Sato et al, 2016). The expression of mintbodies enables tracking
of changes in endogenous histone modification levels without
affecting cell cycle progression and developmental processes in such
model organisms as fission yeast, nematode, drosophila and zebrafish
(Sato et al, 2013; Arai et al, 2017). Here, to follow XCI dynamics in
living cells, we developed a mintbody specific for the PRC2-dependent
H3K27me3. In addition, we implemented sgRNA-dCas9 system to
visualise both X chromosomes in living cells (Chen et al, 2013; Anton
et al, 2014). We used these novel tools in combination with an
H4K20me1-specific mintbody (Sato et al, 2016; Sato et al, 2018) and a
method to visualise endogenous Xist RNA in live cells (Masui et al,
2018; Dossin et al, 2020). This allowed us to show that there are strik-
ing similarities in the accumulation dynamics of both H3K27me3 and
H4K20me1 marks on the Xi. Further ChIP-seq analysis confirmed
concurrent accumulation of H4K20me1 and H3K27me3 during XCI
albeit with rather distinct genomic distributions and correlations with
gene silencing dynamics. By using cells expressing mutant Xist RNA,
we demonstrate that H4K20me1 accumulation, just like that of PcG-
dependent H3K27me3, relies on the Xist RNA B and C repeats. This
also reveals that both marks are dispensable for the initiation of gene
silencing. Taken together, our analysis uncovers that the H4K20me1
and H3K27me3 histone marks accumulate at the Xi with comparable
dynamics but with rather different distributions. Reliance of both
marks on the Xist-BC region for their enrichment suggests a mechanis-
tic link between Polycomb and H4K20me1 accumulation during facul-
tative heterochromatin formation on the X chromosome. These
observations also imply that the general function of H4K20me1 may
be in chromatin compaction that characterises facultative heterochro-
matin rather than in the initiation of gene silencing.
Results
H3K27me3 mintbody (2E12LI) specifically tracks H3K27me3 in
living cells
Methods for tracking polycomb-dependent histone marks in living
cells have been lacking up until now. Such tools would be hugely
beneficial for the study of dynamic epigenetic processes such as XCI.
To address this, we decided to generate an H3K27me3-specific mint-
body. Upon screening of mouse hybridomas, we selected a 2E12
clone, which expresses an H3K27me3-specific antibody. We deter-
mined the cDNA sequence of the IgG heavy and light chains in 2E12
by deep sequencing (Kuniyoshi et al, 2016) and cloned the variable
fragments by PCR to construct a mintbody expression vector (Figs 1A
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and EV1A). To validate that the mintbody properly localises to
H3K27me3-enriched chromatin in living cells, we used mouse terato-
carcinoma cell line MC12 (Abe et al, 1988). MC12 is a mixture of
diploid and tetraploid female cells harbouring one or two Xi, on
which the mintbody is expected to be concentrated. When expressed
in MC12, the superfolder (sf) GFP version of 2E12 mintbody (2E12-
sfGFP) localised mostly in cytoplasm and tended to form aggregates
(Fig EV1B, left), suggesting that 2E12-sfGFP was not able to function
in cells, probably due to a typical problem in folding and/or struc-
tural stability associated with the intracellular expression of scFv
(Cattaneo & Biocca, 1999; Ewert et al, 2004). To prevent aggregate
formation, we performed PCR-based random mutagenesis and tran-
sient transfection into MC12 cells. One mutant that localised preferen-
tially in the nucleus with focal enrichment (presumably Xi) had Met
86 to Leu substitution in the heavy chain (M86L) (Fig EV1B, middle).
Changes in localisation suggested that M86L mutation improved the
mintbody function to bind to H3K27me3. To gain insight into the
contribution of M86L mutation in scFv structure, we looked into the
atomic models built based on the X-ray structure of the most similar
scFv (Fig EV1C, left). The modelling indicated that Met 86 is located
within a hydrophobic core of the heavy chain, and its substitution to
Leu appears to fill the space in the core better than the original Met
to strengthen hydrophobic interactions. We have previously observed
that the hydrophobicity of an amino acid in a hydrophobic core is
important for the functionality of a H4K20me1-mintbody (Sato et al,
2016). However, the 2E12M86L-sfGFP was still not exclusively
located in the nucleus and we were unable to obtain cells stably
expressing it. Thus, we decided to further strengthen scFv folding
with an additional mutation at Met 158 in the light chain’s hydropho-
bic core (Fig EV1C, right). We constructed three mutants in which
Met 158 was substituted to Ile, Leu and Val in 2E12M86L. Among the
three mutations, M185I mutant was the most enriched in the nucleus
with evident foci (Fig EV1B, right). To confirm that nuclear foci of
2E12M86L, M185I (2E12LI)-sfGFP represent H3K27me3-enriched Xi,
we employed immunofluorescence (IF) on transiently expressing
cells using previously characterised specific antibodies directed
against H3K27me3 and H3K9me3 (CMA327 and CMA318, respec-
tively (Chandra et al, 2012)). The nuclear foci were colocalised with
a H3K27me3-specific antibody, but not with H3K9me3-specific anti-
body that is concentrated in Hoechst-dense pericentromeric hete-
rochromatin (Fig 1B). These data are consistent with the mintbody
foci representing Xi in living cells. The utility of 2E12LI mintbody
was further demonstrated by time-lapse imaging of stably expressing
MC12 cells, which allowed for the tracking of Xi during interphase
and mitosis (Fig 1C and Movie EV1).
To further validate the specificity of 2E12LI to H3K27me3, we
performed both biochemical and cell-based assays. We first evaluated
the binding specificity of bacterially expressed and purified 2E12LI-
sfGFP in vitro using a modified histone peptide array (Fig EV2A).
H3K27me3-containing peptides were highlighted over other peptides,
regardless of the neighbouring R26 modifications (Fig EV2B). The
2E12LI-sfGFP binding was, however, occluded by S28 phosphoryla-
tion (S28ph), as commonly observed for methyl-specific antibodies
(Kimura et al, 2008; Hayashi-Takanaka et al, 2011; Kimura, 2013).
Next, we assessed whether the purified 2E12LI-sfGFP can selectively
bind to H3K27me3 in cells by manipulating the level of specific
methylation. HeLa cells were transfected with HaloTag-tagged lysine
demethylases KDM6B and KDM4D and fixed for staining with the
specific antibodies or 2E12LI-sfGFP. Consistently with the substrate
specificity of these KDMs, IF indicated that HeLa cells overexpressing
Halo-KDM6B and Halo-KDM4D exhibited drastic decrease of
H3K27me3 and H3K9me3, respectively (Fig EV2C and D). The result
of staining with purified 2E12LI-scFv was similar to H3K27me3-speci-
fic antibody, showing decreased levels of H3K27me3 by Halo-KDM6B
overexpression and no changes in H3K27me3 by Halo-KDM4D (Fig
EV2E and F). Taken together with the immunofluorescence pattern
and biochemical analysis, we concluded that 2E12LI-sfGFP selectively
binds to H3K27me3 over the other modifications including H3K9me3.
For convenience, we now call 2E12LI fused with a fluorescent protein
as H3K27me3-mintbody.
Simultaneous tracking of X chromosome loci, H3K27me3 and
H4K20me1 during XCI
In order to visualise the dynamics of histone modifications during
XCI, we decided to develop a method to identify the X chromosome
mintbody

















Figure 1. Establishing H3K27me3 mintbody to visualise H3K27me3 in living cells.
A Schematic representation of the mintbody. H3K27me3-specific single-chain variable fragment (scFv) is genetically fused with a fluorescent protein (FP).
B Immunofluorescence (IF) validation of mintbody specificity. Mouse MC12 cells, which stably express H3K27me3-mintbody (sfGFP), are labelled with antibodies specific
for H3K27me3 (Cy5) and H3K9me3 (Cy3). DNA is stained with Hoechst33342. Single confocal sections are shown. Arrows mark Xi. Scale bar = 10 μm.
C Time-lapse imaging of a dividing MC12 cell stably expressing H3K27me3-mintbody (sfGFP). Projection images of 7 confocal sections with 2 μm intervals are shown
with elapsed time (hh:mm). Scale bar = 10 μm.
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in live cells. We used an sgRNA-dCas9 (single guide RNA-nuclease
dead Cas9) system to label X-linked loci in living cells (Anton et al,
2014; Ma et al, 2015). We screened repetitive sequences located
specifically on the mouse X chromosome and chose 32 microsatel-
lite sequences as target candidates. The expression vectors for
sgRNAs that bind to the sequences were constructed and cotrans-
fected with an expression vector for EGFP-tagged dCas9 into MC12
cells. Among them, 4 sgRNAs (mX2, mX8, mX18 and mX26)
enabled visualising X-linked loci in living cells (Fig EV3). We








































































































Figure 2. Simultaneous visualisation of histone marks and X chromosome loci in living cells.
A Schematic diagram of CRISPR/dCas9-3×sfGFP targeting loci on mouse X chromosome. sgRNA mX26 and mX8 target microsatellite repeats on Dxz4 and Xist loci,
respectively.
B Experimental design: female ESCs are engineered to stably express two sgRNAs, dCas9-3xsfGFP and a nuclear localisation signal (NLS)-fused H3K27me3-mintbody
(mCherry). Upon ESC differentiation by LIF withdrawal H3K27me3 accumulation occurs at the inactivating X (Xi) but not at the active X (Xa). Green foci allow marking
of two X-linked loci (Dxz4 and Xist).
C Live imaging of female mESCs as in (B) in undifferentiated conditions (+LIF) or upon 3 days of LIF withdrawal. Double arrowheads mark Xa and single arrowhead
marks Xi. Shown are maximum intensity projections of 11 z-plane confocal sections. Scale bar = 10 μm.
D ESCs as in (B) were engineered to express H3K27me3-mintbody (SNAP/JF646) and H4K20me1-mintbody (mCherry). Cells were cultured in the absence of LIF for
2 days. Time-lapse images for 12 z-plane confocal stack were acquired every 1 h. Maximum intensity projection images are shown with elapse time (hh:mm).
Arrowheads mark Xi. Scale bar = 10 μm.
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chromosomes and used 3×sfGFP-tagged dCas9 (3×sfGFP-dCas9), to
amplify the signal for further analyses using ESCs.
To track H3K27me3 during X inactivation, we established female
mouse ESCs (PGK12.1) expressing two sgRNA (mX8 and mX26),
3×sfGFP-dCas9 and H3K27me3-mintbody (mCherry version) (Fig 2
A and B). In undifferentiated ESCs, X chromosome loci were identi-
fied as 2 pairs of 3×sfGFP-dCas9 spots and H3K27me3-mintbody
was not enriched in either allele (Fig 2C, upper panels). In contrast,
3 days after withdrawal of leukaemia inhibitory factor (LIF),
H3K27me3-mintbody accumulated around one pair of 3×sfGFP-
dCas9 spots (Fig 2C, lower panels). This result demonstrated that
H3K27me3-mintbody together with the sgRNA-dCas9 system allows
for tracking the dynamics of histone modification in living and dif-
ferentiating cells. Since H4K20me1, unlike H4K20me2/3, also
becomes enriched on Xi (Fig EV4A; Kohlmaier et al, 2004), we
sought to reveal the relative accumulation kinetics of the H3K27me3
and H4K20me1 histone modifications during XCI. We established
ESCs expressing the two sgRNAs, 3×sfGFP-dCas9, H3K27me3-mint-
body (SNAP-Tag version, visualised with JF646) and H4K20me1-
mintbody (mCherry version, (Sato et al, 2016)) and induced dif-
ferentiation (3d LIF withdrawal). Time-lapse imaging revealed that
whenever H3K27me3 accumulation was visible at the Xi, some level
of H4K20me1 enrichment was also discernible (Fig 2D), suggesting
that both repressive marks accumulate concurrently during XCI.
This initial analysis in differentiating female ESCs confirmed the
successful use of both H3K27me3- and H4K20me1-mintbodies to
follow enrichment of these two marks on the X chromosome.
However, given the asynchronous nature of random XCI in differen-
tiating ESCs and the rather weak signal from the tagged X-linked
loci, it was challenging to distinguish the Xi from the active X (Xa)
prior to a significant accumulation of both repressive chromatin
marks on the Xi. To ameliorate our analysis, we therefore decided
to follow Xist RNA itself in living cells alongside H3K27me3 or
H4K20me1.
H3K27me3 accumulates concurrently with H4K20me1 at the Xi
In order to track the relative dynamics of H3K27me3, H4K20me1
and Xist RNA during XCI, we combined the use of mintbodies with
the inducible Xist-Bgl system (Masui et al, 2018; Dossin et al, 2020;
Fig 3A). The latter model is based on the hybrid (Mus musculus
castaneus x C57BL/6) TX1072 female ESCs line allowing for doxycy-
cline (DOX) induction of the endogenous Xist gene from C57BL/6
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Figure 3. Simultaneous visualisation of histone marks and Xist RNA in living cells.
A Schematic representation of the experimental design. Female mouse ESC line was used, in which Xist can be induced from one allele (TX1072) and this allele also
harbours an array of 18 Bgl stem loops (BglSL) inserted into the 7th exon of Xist gene. BglG fused to a fluorescent protein (GFP or mCherry) detects Xist RNA as it binds
to BglSL. Cells also stably express a mintbody allowing the detection of H3K27me3 (GFP) or H4K20me1 (mCherry).
B Cells were treated with DOX to induce Xist expression and time-lapse imaging was performed with images acquired every 15 min. Maximum intensity projection
images are shown with elapse time (hh:mm). Arrowheads mark Xi accumulating Xist RNA. Scale bar = 5 μm.
C Live imaging analysis of average H3K27me3 (red) and H4K20me1 (blue) accumulation at the Xi. Average normalised mintbody enrichment is shown with shading
representing 25 and 75 quartiles. Signal was calculated starting from the first accumulation of Xist RNA. At least 30 cells were analysed. *unpaired t-test
P-value < 0.05.
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expression and thus reduce the level of heterogeneity observed
during XCI in differentiating ESCs. In addition, 18 Bgl RNA stem
loops (BglSL) were knocked into the 7th exon of DOX-inducible Xist
(Fig EV4B) (Dossin et al, 2020). To track Xist RNA accumulation,
BglSL are visualised by a BglG protein fused to either EGFP or
mCherry and expressed from the Rosa26 or TIGRE locus (Fig EV4C
and D). The cell lines enabling Xist RNA visualisation are named
TX-Xist-EGFP and TX-Xist-mCherry. These cell lines were used to
generate stably expressing PiggyBac transgenes for the H3K27me3-
or H4K20me1-mintbodies (Fig EV4C and D). Two ESC lines, TX-
Xist-EGFP; H4K20me1-mCherry and TX-Xist-mCherry; H3K27me3-
sfGFP were used for subsequent analyses. Importantly, the use of
Xist-BglSL or the mintbodies did not affect the efficiency of gene
silencing during XCI (Fig EV4E).
In order to visualise the earliest events following Xist RNA accu-
mulation, we started live imaging of ESCs 5 min after DOX induc-
tion (Fig 3B, Movies EV2–EV3). Imaging was performed for at least
6 h in 15-min intervals allowing for single-cell tracking and detailed
quantitative analysis. Xist RNA domains appeared after 2–6 h of
DOX induction (Fig EV4F) and were segmented using the Xist-
EGFP/mCherry signal. The mintbody enrichment within such
domains was measured and followed in individual cells throughout
the length of the experiment (Fig 3C). Of note, unlike H3K27me3-
mintbody, H4K20me1-mintbody shows increased nuclear signal
during G2/M phase of the cell cycle, thus tracking the oscillations in
H4K20me1 levels (Sato et al, 2016). We thus excluded mitotic cells
from the analysis due to very high overall levels of H4K20me1.
Next, we followed the enrichment of H3K27me3/H4K20me1 signal
in at least 30 nuclei individually synchronised to the time point
when Xist RNA enrichment was first observed (i.e., typically 2–6 h
after DOX addition). A significant enrichment of both histone marks
was observed within the Xist RNA domain about 45 min after Xist
RNA appearance (adj. P-value < 0.05; Fig 3B and C). Initial accu-
mulation of H3K27me3 and H4K20me1 followed very similar
dynamics. However, after 2.5 h the two marks significantly diverged
(Fig 3C). Indeed, H3K27me3 continued to rapidly accumulate, while
the increase in H4K20me1 enrichment significantly slowed down
(Fig 3C). Thus, we have successfully performed simultaneous track-
ing of Xist RNA and repressive histone marks. In summary, the
enrichment of both H3K27me3 and H4K20me1 is delayed compared
to Xist RNA accumulation by about 45 min. H3K27me3 shows a
continued accumulation over time while that of H4K20me1 eventu-
ally slows down. This reveals that the two marks share similar
dynamics of enrichment but only at the early stages of XCI.
Allele-specific native ChIP-seq reveals similarities between
H3K27me3 and H4K20me1 accumulation dynamics
Given the above results indicating that although H3K27me3 and
H4K20me1 are both initially enriched soon after Xist RNA accumula-
tion, their patterns diverge after a few hours, we decided to investigate
the molecular distributions of both these marks along the Xi. To this
end, we performed allele-specific native ChIP-seq (nChIP-seq) for
H4K20me1 in the hybrid female cell line TX1072 (Schulz et al, 2014).
Thanks to an inducible Xist gene on the B6 chromosome, DOX addition
leads to rapid gene silencing and chromatin mark alterations that can
be measured allelically thanks to the high rate of polymorphism
between the B6 and Cast X chromosomes (Zylicz et al, 2019). Following
DOX treatment, we tracked H4K20me1 accumulation on the Xist RNA-
coated B6 allele across five time points at up to 4-h resolution on biolog-
ical duplicates (Fig 4A). We compared all our results with a matched
published dataset of H3K27me3 (Zylicz et al, 2019). Importantly, we
validated the specificity of H4K20me1 antibody using a peptide array
(Fig EV5A) and controlled for Xist RNA induction efficiency (Fig
EV5B). Upon sequencing, reads were split according to content of
allele-specific single nucleotide polymorphisms (SNPs: B6 mapping to
Xi; Cast mapping to Xa). Such allelic information was analysed, reveal-
ing progressive enrichment of B6-specific reads (originating from Xi)
upon Xist induction for H4K20me1 as is the case for H3K27me3 (Fig
EV5C). We analysed relative B6-read enrichment within 10-kb windows
across the whole X chromosome normalised to t = 0 h (Fig 4B). This
revealed H4K20me1 accumulation after 8 h of DOX induction, a time
point when H3K27me3 also starts to accrue but significantly later than
initial H2AK119Ub enrichment (Zylicz et al, 2019). The levels of enrich-
ment for H4K20me1 are lower than for H3K27me3 and seem to reach
their plateau earlier. To better visualise the timing of accumulation, we
normalised both marks to their effective dynamic range, i.e. to average
accumulation after 24 h of DOX induction (Fig 4C). This confirmed that
after 8 h of DOX treatment, there is concurrent initiation of H4K20me1
and H3K27me3 accumulation. To quantify this further, we plotted the
B6-read enrichment relative to t = 0 h of each 10-kb window as a func-
tion of time and fitted a sigmoidal curve (see Materials and Methods).
To extract the information about relative timing of histone mark accu-
mulation, we obtained the time when each curve reaches its maximum
slope (effective dose 50%, ED50). ED50 analysis revealed that
H4K20me1 reaches its most efficient accumulation prior to H3K27me3
(Fig 4D) but later than H2AK119Ub (Zylicz et al, 2019). This is in line
with H4K20me1 achieving its plateau significantly before H3K27me3.
Thus, our analysis confirmed live imaging observations that H4K20me1
accumulates concurrently with H3K27me3 but quickly reaches maxi-
mum enrichment (Fig 3C).
We next examined the degree to which the distributions of the
two marks overlapped across the Xi. We found that H4K20me1
becomes preferentially enriched at loci in proximity to the Xist gene
(green bar) as well as at regions that Xist RNA first interacts with (so
called “entry sites”, black bars (Pinter et al, 2012); Fig 4E). The
initial enrichment of H4K20me1 on the Xist-coated X follows the
same pattern previously detected for not only H3K27me3 but also for
PRC1-dependent H2AK119Ub (Fig 4E; Zylicz et al, 2019). To confirm
this observation, we investigated chromosome-wide correlation
between H3K27me3 and H4K20me1 accumulation within different
genomic windows (Fig 4F). Consistently with our initial observation,
we found striking correlation in the accumulation of both marks
across intergenic windows as well as bodies of silent genes. In
contrast, the bodies of genes that were active prior to DOX treatment
(i.e. initially active genes) showed a much lower Pearson’s correla-
tion with ρ = 0.2, implying that both marks differ in their correlation
with transcription (see below). With the exception of initially active
genes, nChIP-seq of H4K20me1 revealed that its accumulation
follows a strikingly similar pattern and dynamics to H3K27me3.
H4K20me1 accumulates intergenically and is dispensable for
XCI initiation
The above nChIP-seq analysis revealed similarities and differences
between H4K20me1 and H3K27me3 accumulation on the X during
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XCI. While investigating genes that are initially active and then
become silenced following Xist induction, we observed that
H4K20me1 is strongly biallelically enriched (premarked) at tran-
scribed gene bodies, prior to silencing (Fig 5A). This contrasts
strikingly with the distribution of H3K27me3, which never
premarks initially active genes (Zylicz et al, 2019). We confirmed
that this H4K20me1 enrichment at transcribed genes is a general
feature both on the X chromosome (Fig 5B) and autosomes (Fig
EV5D). This is in line with previous reports indicating that
H4K20me1 correlates with transcriptional elongation and is
enriched at active gene bodies (Beck et al, 2012; Kapoor-Vazirani &
Vertino, 2014; Veloso et al, 2014). Upon Xist induction (+ DOX),
we found a significant accumulation of H4K20me1 on the Xi at
initially active promoters and intergenic regions (Fig 5A and B).
This resembles the pattern observed for H3K27me3, with the
intriguing caveat that H4K20me1 does not seem to further accumu-
late at bodies of initially active genes, rather, H4K20me1 levels
remain constant. Thus, H4K20me1 and H3K27me3 accumulation
patterns are strikingly similar within intergenic regions but differ
in the bodies of initially active genes (Fig 4F). Next, to evaluate the
relationship between H4K20me1 accumulation and the process of
gene silencing, we separately analysed genes inactivated early and
late upon DOX treatment (Fig 5C). This revealed that while
H4K20me1 de novo accumulation following Xist induction is
restricted to intergenic and promoter regions, it occurs more effi-
ciently in the proximity of rapidly silenced genes e.g. of Rnf12
(Fig 5A). All in all, these findings suggest that prior to XCI,
H4K20me1 correlates with active transcription (in gene bodies),
but following Xist induction H4K20me1 becomes enriched de novo
at regions surrounding genes that are rapidly silenced.
To further explore the potential relationship of H4K20me1
enrichment and H3K27me3 deposition during XCI, we decided to
investigate chromatin states in Xist mutant cell lines. Current
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Figure 4. Native ChIP-seq reveals H4K20me1 and H3K27me3 co-accumulation during XCI.
A Schematic representation of the experimental design. The hybrid TX1072 mouse female ESC line was used, in which Xist can be induced from the endogenous B6
allele. Time course nChiP-seq for H4K20me1 was performed and compared to a published H3K27me3 dataset (GSE116480) (Zylicz et al, 2019).
B Quantification of average H4K20me1 (blue) and H3K27me3 (red) enrichment at the Xi (B6 allele) compared with t = 0 h in 10-kb windows spanning the whole
chromosome. Shading is the interquartile range.
C As in (B) but shown is normalised B6 enrichment to the average accumulation at 24 h.
D Pairwise comparison of H4K20me1 and H3K27me3 accumulation dynamics (ED50) at the X chromosome. All 10-kb windows with ED50 < 24 h are plotted. * aired
Wilcoxon rank-sum test P-value < 0.05.
E H4K20me1 (blue) and H3K27me3 (red) accumulation across the Xi after 12 h of DOX treatment. The black line is a locally estimated scatterplot smoothing (LOESS)
regression on all 10-kb windows (dots). Below each plot shown is the Xist locus (green bar) and Xist entry sites (black bars).
F Correlation between H3K27me3 and H4K20me1 accumulation after 24 h of DOX treatment at initially active gene bodies (left), inactive gene bodies (middle) and 10-
kb intergenic windows spanning the X chromosome (right). All scales are logarithmic. All correlations (ρ) are with P < 0.01 from Pearson’s correlation test.
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machinery, involving initial PRC1 recruitment by the B and C
repeats of Xist and subsequent PRC2 recruitment thanks to
H2AK119Ub enrichment (Almeida et al, 2017; Pintacuda et al, 2017;
Bousard et al, 2019; Colognori et al, 2019; Nesterova et al, 2019).
We therefore tested whether H4K20me1 enrichment at the Xi is also
dependent on the B and C regions of Xist RNA. To this end, we
employed previously established male ESC lines harbouring a DOX-
inducible, endogenous Xist in either its full length form (XistFL) or
lacking the B and C repeat regions (XistΔBC) (Fig 6A), in which
H3K27me3 changes on the Xi had already been mapped (Bousard
et al, 2019). This system recapitulates hallmarks of XCI, namely
chromosome-wide Xist coating, X-linked gene silencing and hete-
rochromatin formation (Bousard et al, 2019). After DOX treatment,
we performed IF/RNA FISH experiments to quantify the efficiency
of H4K20me1 enrichment at the Xist RNA domains (Fig 6B). While
the global level of H4K20me1 was comparable in both cell lines, it
showed, as predicted, striking variability between cells due to dif-
ferent cell cycle stages. Nevertheless, we observed complete loss of
H4K20me1 enrichment from the Xist RNA domains when XistΔBC
was expressed; a result reminiscent of what was previously
observed for H3K27me3 (Fig 6C) (Bousard et al, 2019). These data
indicate that H4K20me1 enrichment depends on the same regions of
Xist RNA that are involved in recruiting PRC1 and lead to subse-
quent PRC2 recruitment. Which factors directly allow for
H4K20me1 enrichment at the Xi still remains unclear, however.
Another important conclusion from this result pertains to gene
silencing. Indeed, the XistΔBC RNA is able to initiate gene silencing,
albeit at slightly lower efficiency (Bousard et al, 2019). This implies
that the de novo accumulation of H4K20me1 is largely dispensable
for the initiation of gene silencing, similarly to both Polycomb-asso-
ciated H3K27me3 and H2AK119Ub.
Discussion
We report the spatio-temporal dynamics of two early chromatin
changes, H4K20me1 and H3K27me3 during the formation of faculta-
tive heterochromatin in XCI. Using a unique combination of live-cell
imaging and chromatin profiling in the same cell systems, we reveal
the relative timing and distributions of chromatin enrichment for
these marks during X inactivation. Our study provides insights into
the process of XCI and new tools for the study of epigenetic
processes in general. Indeed, we use the powerful technology of
mintbodies, genetically encoded fluorescent probes that can detect
specific proteins and their modifications. In this way, we visualise
the distribution and levels of specific histone modifications, in longi-
tudinal single-cell analyses of the epigenetic process of XCI. We
previously reported on the development of mintbodies specific for
H4K20me1 and H3K9ac (Sato et al, 2013; Sato et al, 2016). The
H3K27me3 mintbody developed here will enable the study of PRC2-
dependent epigenetic mechanisms beyond XCI.
Our results reveal that first detectable enrichment of both
H3K27me3 and H4K20me1 on the Xist-coated X chromosome occurs
about 45 min following Xist RNA coating, thus ~ 3–7 h after DOX
treatment. This suggests that both marks become enriched on the Xi
in a Xist-dependent but likely indirect mechanism. It should be
noted that proteins such as SPEN which are recruited directly by
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Figure 5. H4K20me1 accumulates intergenically.
A Genome browser tracks showing H3K27me3 (top) and H4K20me1 (bottom) accumulation at a gene silenced rapidly (Rnf12) or more slowly (Pgk1). Allele-specific tracks
were overlaid (B6 in red and Cast in blue). Note strong H4K20me1 bi-allelic premarking at gene bodies.
B Average H3K27me3 (top) and H4K20me1 (bottom) enrichment at the B6 allele over initially active or inactive genes  30 kb at the X chromosome. Shown are data for
all time points.
C Average H4K20me1 enrichment at the B6 allele over early and late silenced genes  30 kb at the X chromosome. Shown is data for all time points.
Data information: TSS: transcription start site; TES: transcript end site.
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show immediate colocalisation with Xist during initiation of XCI
based on live-cell imaging using the same ESC system (Dossin et al,
2020). While the initial enrichment of both H4K20me1 and
H3K27me3 follows similar dynamics, they soon diverge with
H3K27me3 accumulating more efficiently. What is more, H4K20me1
shows a unique cell cycle dynamics with transiently increased levels
during G2/M (Rice et al, 2002). In line with these differences, our
nChIP-seq analysis revealed that both marks also show distinct
genomic distribution especially in the context of initially active
genes. Thus, while accumulation of both marks depends on a
common Xist-mediated mechanism their spreading and long-term
enrichment is regulated independently.
Here, we reveal that both H3K27me3 and H4K20me1 accumula-
tion depends on the Xist B + C region (Bousard et al, 2019).
However, neither SETD8 nor PRC2 core components have been
identified as direct Xist RNA-binding proteins (Chu et al, 2015;
McHugh et al, 2015; Minajigi et al, 2015). Instead, PRC1 is thought
to be recruited by this region via the hnRNPK factor. Furthermore,
SETD8 does not interact with any of the five proteins, including
hnRNPK, recently identified to bind with the Xist B + C repeats
(Bousard et al, 2019). It thus remains unclear how SETD8, if at all,
is recruited to the Xi and whether it depends on the non-canonical
PRC1 complexes, as proposed for PRC2 (Almeida et al, 2017; Pinta-
cuda et al, 2017). Indeed, PRC2 recruitment depends on the non-
canonical PRC1, which very rapidly deposits H2AK119Ub. This
modification in turn is proposed to recruit PRC2 via its cofactors,
e.g. JARID2 (Cooper et al, 2016). Whether a similar mechanism
mediates H4K20me1 enrichment remains unclear. A factor poten-
tially involved in indirect SETD8 recruitment is a Polycomb-group
protein L3MBTL1, which is not however a cofactor of either PRC1
or PRC2. L3MBTL1 is a binder of H4K20me1 (Kalakonda et al,
2008) but it also interacts with SETD8 and H3K27me1/2 (Kalakonda
et al, 2008). Thus, L3MBTL1 may recruit SETD8, when H3K27 starts
to become methylated by PRC2 but the H3K27me1/2 enrichment
during XCI has not yet been studied. In line with this model, loss of
EED, a core PRC2 component, has previously been reported to result
in partially reduced H4K20me1 enrichment at the Xi (Schoeftner
et al, 2006). Thus, PRC2 contributes to H4K20me1 accumulation but
other pathways must also operate. Alternatively, it is possible that
SETD8 is not recruited to the Xi; instead, it could be the enzymes
catalysing H4K20me2 demethylation to H4K20me1, which become
enriched during XCI. Indeed, in C. elegans dosage compensation,
which consists of a reduction of X-linked gene activity in XX individ-
uals, is partly dependent on an H4K20me2-specific demethylase
(Brejc et al, 2017). In this system, efficient conversion of H4K20me2
to H4K20me1 at the X chromosome by DPY-21 promotes gene
silencing during the maintenance phase. RSBN1 and RSBN1L are
mouse orthologs of DPY-21 and seem to retain specific histone
demethylase activity (Brejc et al, 2017). Whether RSBN1/RSBN1L
have a role in H4K20 methylation dynamics in mammalian cells and
whether these factors play a role in XCI merits further investigation.
Finally, it is also possible that H4K20me1 enrichment at the Xi is
due to hindered conversion to higher methylation states by SUV4-
20H1/2.
Identifying the B and C repeats of Xist RNA as the key region for
H4K20me1 enrichment during XCI suggests that this mark may only
play a minor role in initiating gene silencing. Indeed, cells express-
ing Xist:ΔBC can induce X chromosome gene silencing during XCI
albeit with lower efficiency (Bousard et al, 2019). The fact that
H4K20me1 is highly enriched at transcribed gene bodies both on the
X chromosome (before XCI) and autosomes would also suggest that
this mark is not involved in transcriptional repression. Indeed,
previous studies reported a positive correlation between H4K20me1
enrichment and the rate of transcriptional elongation (Veloso et al,
2014). SETD8 was also proposed to facilitate RNA Polymerase II
(RNAPII) release from promoters (Kapoor-Vazirani & Vertino, 2014;
Nikolaou et al, 2017). The initial distribution of H4K20me1 is in line
with such findings. However, this mark also persists at genes which
become rapidly silenced during XCI, e.g. Rnf12 (Fig 5A). Thus, tran-
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Figure 6. H4K20me1 accumulation relies on Xist B + C repeat region.
A Schematic representation of the experimental design. By DOX addition, male TXY mouse ESC lines allow for expression of full length XistFL or XistΔBC. Cells induced
for 48 h in the absence of LIF were used for combined IF and RNA FISH.
B Representative image of IF/RNA FISH for Xist RNA and H4K20me1 in cells expressing XistFL or XistΔBC. Arrowheads point to the Xist RNA domains. Scale bar = 5 μm.
C Graph represents the mean %  StDev of Xist RNA domains enriched for H4K20me1 (left) or H3K27me3 (right) in cells expressing XistWT or XistΔBC. Shown are
averages from at least 2 independent experiments; minimum of 50 Xist RNA domains were counted per experiment; only P-values corresponding to significant
differences from unpaired Student’s t-test comparing mutants to Xist FL are indicated as * (P-value < 0.05). Data for H3K27me3 was extracted from published data
(Bousard et al, 2019).
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gene bodies indicating that SETD8 is not directly recruited by the
RNAPII. The fact that H4K20me1 remains in gene bodies even as
silencing occurs and that it accumulates in intergenic regions during
XCI suggests that it may play a rather different role. Indeed, such a
mark may be coupled both to transcriptional elongation and to gene
silencing in the context of XCI, if it plays a role in genome stability
and/or chromatin structure (Schotta et al, 2008), rather than in gene
transcriptional regulation per se.
While H4K20me1 is dispensable for the initiation of gene silenc-
ing, it might participate in chromatin compaction during XCI.
Indeed, DNA FISH analysis of cells depleted of SETD8 previously
revealed some decompaction of the Xi (Oda et al, 2009). The finding
that H4K20me1 predominantly accumulates intergenically upon Xist
induction might support this conclusion. Consistently, in C. elegans
loss of H4K20me1 enrichment at the X chromosome leads to a
decrease in long-range interactions, suggesting impaired chromatin
compaction (Brejc et al, 2017). How H4K20me1 might mediate such
a process is still far from clear. One factor likely to be involved is
L3MBTL1, which becomes recruited to H4K20me1 during S-phase
(Trojer et al, 2007; Kalakonda et al, 2008). In vitro, L3MBTL1
compacts nucleosomes in a H4K20me1/2-dependent manner (Trojer
et al, 2007). However, the involvement of L3MBTL1 in XCI and
chromatin compaction remains to be defined.
In conclusion, we have applied a unique combination of mint-
bodies to track PRC2-dependent H3K27me3 and H4K20me1 in living
cells, together with a high resolution ChIP-seq analysis to define the
precise spatio-temporal distribution of these chromatin marks across
the X chromosome during the initiation of XCI. Our approach has
uncovered that H3K27me3 and H4K20me1 become enriched thanks
to the same B + C region of Xist RNA but that the subsequent accu-
mulation dynamics of these marks is rather different during XCI.
While de novo H4K20me1 enrichment is dispensable for the initia-
tion of gene silencing, it might contribute to chromatin compaction
during XCI. These observations may have implications for the more
general chromatin function of H4K20me1 across the genome.
Materials and Methods
Cloning variable fragments of H3K27me3-specific antibody
and mutagenesis
Mouse hybridoma clone 2E12 was generated and screened by Mab
Institute Inc. as described (Kimura et al, 2008). RNA was extracted
from cells using TRIzol (Thermo Fisher Scientific) for RNA-seq and
de novo transcriptome assembly to determine cDNA sequence
encoding the IgG heavy and light chains, according to Kuniyoshi
et al (2016). To amplify variable regions of heavy (VH) and light
(VL) chains, PrimeScript II High Fidelity One step RT-PCR Kit




GATTTCCAGCTTGGTGCCTCC. As described previously (Sato et al,
2013), the heavy and light chains were connected by PCR (seven
cycles) using the amplified fragments with the following oligonu-
cleotides to have a flexible linker: LINK primer1, GTCTCCTCAGGTG
GAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGATCG; and
LINK primer2, CGATCCGCCACCGCCAGAGCCACCTCCGCCTGAACC
GCCTCCACCTGAGGAGAC. The resulting scFv fragments were
further amplified (20 cycles) using the 50 and 30 primers: scFv
primer_s, CTCGAGCTCAAGCTTCGAATTCGCCATGGCCCAGG and
scFv primer_as: CATGGTGGCGACCGGTGGATCCGCCCGTTTTATTT
CCAG, for cloning into psfGFP-N1 vector (Addgene #54737)
digested with EcoRI and BamHI to yield psfGFP-N1-2E12 using In-
Fusion (Takara).
Error-prone PCR was performed to make a few amino acid
substitutions in the scFv region using psfGFP-N1-2E12 as a template
and a set of primers (scFv primer_s and scFv primer_as) with Taq
DNA Polymerase (QIAGEN) in the presence of MnCl2 (six cycles)
(Wilson & Keefe, 2000).
Site-directed mutagenesis was performed by inverse PCR using a
mutant clone that contained M86L mutation (psfGFP-N1-2E12M86L)
as a template with PrimeSTAR HS DNA polymerase (Takara) and
primers to introduce M185I substitution: a472t_s, TGTCAGTTGGA
GAGAAGGTTACTTTGGCCTGCAAGT; and a472t_as, ACTTGCAGGC
CAAAGTAACCTTCTCTCCAACTGACA.
Mintbody expression in HeLa and MC12 cells
HeLa and MC12 cells were described previously (Sato et al, 2016).
Transfection was performed using Fugene HD (Promega) or Lipofec-
tamine 2000 (Thermo Fisher Scientific) according to the manufac-
turer’s instructions. To obtain stably expressing cells, scFv-sfGFP
was cloned into PB533A (System Biosciences) and transfected with
the transposase expression vector (PB200PA-1; Systems Bios-
ciences). The day after transfection, cells were grown in 1 mg/ml
G418 (Nacalai Tesque) for 1–2 weeks, and fluorescent cells were
collected using a cell sorter (SH800; Sony). Single-cell clones were
obtained by limiting dilution into 96-well plates and microscopic
investigation.
For live-cell imaging, cells were plated onto a glass bottom dish
(Mat-Tek; P35G-1.5-14-C), or a glass bottom plate (AGC Techno
Glass; 24-well or 96-well) in FluoroBrite DMEM (Thermo Fisher
Scientific) containing 10% FCS (Thermo Fisher Scientific) and 1%
Glutamine-Penicillin-Streptomycin solution (Sigma-Aldrich). A glass
bottom dish or a plate was set on to a heated stage (Tokai Hit) with
a CO2 control system (Tokken) on an inverted microscope (Nikon
Ti-E) or on a confocal system (Nikon Ti-E with Yokogawa CSU-W1
spinning disk or Olympus FV1000) to maintain cells at 37°C under
5% CO2 atmosphere.
For immunofluorescence, MC12 cells expressing H3K27me3-
mintbody (2E12LI-sfGFP) were fixed with 4% formaldehyde (Elec-
tron Microscopy Sciences) in 250 mM HEPES-NaOH (pH 7.4; Wako
Purechemicals) containing 0.1% Triton X-100 for 10 min at room
temperature. Fixed cells were permeabilised with 1% Triton X-100
in PBS for 20 min at room temperature and washed three times with
PBS. After blocking with 10% Blocking One-P (Nacalai Tesque) in
PBS for 20 min at room temperature, cells were incubated in 2 μg/
ml Cy3-conjugated anti-H3K9me3 (CMA318/2F3; Hayashi-Takanaka
et al, 2011) and 2 μg/ml Cy5-conjugated anti-H3K27me3 (CMA323/
1E7; Hayashi-Takanaka et al, 2011) for 2 h at room temperature.
After washing three times with PBS, cells were incubated with 1 μg/
ml Hoechst33342 in PBS for 20 min at room temperature. Fluores-
cence images were sequentially collected using an Olympus FV1000
equipped with a 60× PlanApoN (NA 1.40) oil-immersion lens.
10 of 17 EMBO reports e51989 | 2021 ª 2021 The Authors
EMBO reports Sjoerd JD Tjalsma et al
Bacterial expression and purification of mintbody
2E12LI-sfGFP was subcloned into pMAL-c5X (New England Biolabs)
to obtain an MBP-2E12LI-sfGFP expression vector (pMAL-c5X-
2E12LI-mintbody). Escherichia coli ER2523 cells (NEB Express; New
England Biolabs) harbouring the pMAL-c5X-2E12LI-mintbody plas-
mid were grown in 2 ml Plus grow medium (Nacalai Tesque)
containing 100 μg/ml ampicillin at 26°C overnight. The whole 2 ml
overnight culture was added to 50 ml Plus grow medium, and cells
were grown at 26°C for 1 h before the addition of 0.1 mM isopropyl-
β-d-thiogalactopyranoside (IPTG). Cells were further grown for 8 h
at 26°C and collected by centrifugation (4,000 × g; 10 min; 4°C),
and the pellet was stored at −30°C. After thawing on ice, the pellet
was resuspended in 2.5 ml of Column Buffer (20 mM Tris–HCl, pH
8.0, 200 mM NaCl, 1 mM EDTA), and cells were disrupted using a
sonicator (Branson; Sonifier 250; Output 1.2, Duty Cycle 30%,
4 min with intervals on ice). After centrifugation (2,000 g; 10 min;
4°C), the supernatant was collected, diluted 7-fold with Column Buf-
fer and mixed with 200 μl amylose resin (New England Biolabs) that
were pre-equilibrated with Column Buffer. After washing with
15 ml Column Buffer, bound proteins were eluted with 1.5 ml
Column Buffer containing 20 mM maltose. To remove MBP moiety,
the concentration of eluted MBP-mintbody was adjusted to 1 mg/ml
and digested with 30 μg/ml Factor Xa (New England Biolabs) for
24 h. The cleavage was confirmed by 10–20% SDS-polyacrylamide
gel electrophoresis (SDS–PAGE). After the buffer was replaced with
20 mM sodium phosphate (pH 5.5) buffer containing 25 mM NaCl
using a PD MiniTrap G-25 column (GE Healthcare), the digested
sample was applied to a HiTrap Q HP column and every 1.5 ml was
collected during the application and washing with the same buffer.
Fractions containing H3K27me3-mintbody (2E12LI-sfGFP), analysed
by 10–20% SDS–PAGE, were concentrated using an Amicon Ultra
filter unit (Merck; 10 k cut-off).
For peptide array analysis, a MODified Histone Array (Active
Motif) was blocked for 1 h at room temperature in Blocking One
(Nacalai Tesque) and incubated for 3 h with 0.4 μg/ml H3K27me3-
mintbody in Can Get Signal (Toyobo). After washing three times for
5 min in Tris-buffered saline (20 mM Tris–HCl, pH 8.0, 150 mM
NaCl) containing 0.1% Triton X-100 (TBST), the peptide array was
incubated for 1 h with horseradish peroxidase-conjugated anti-GFP
(Anti-GFP pAb-HRP-DirecT; 1: 2,000 dilution; MBL) and washed 3
times for 10 min in TBST. Signals were developed using Western
Lightning Plus-ECL (PerkinElmer) and detected using a Lumino-
Graph II (ATTO).
For immunofluorescence, HeLa cells were plated in a 24-well
glass bottom plate (IWAKI) and transfected with expression vectors
for HaloTag-tagged KDM6B and KDM4D. Twenty-four hours after
transfection, the cells were fixed, permeabilised and blocked as
described above. The cells were incubated for 1 h at room tempera-
ture with 5 μg/ml H3K27me3-mintbody, 2 μg/ml Alexa Fluor 488-
conjugated anti-H3K27me3 (CMA323/1E7), or 2 μg/ml Alexa Fluor
488-conjugated anti-H3K9me3 (CMA318/2F3) in 10% Blocking One-
P (Nacalai Tesque) containing 1 μg/ml Hoechst33342 and Janelia
Fluor 646 HaloTag Ligand (a gift from Luke Lavis). After washing
three times with PBS, fluorescence images were sequentially
collected using Nikon Ti-E equipped with a 40 × PlanApo (NA 0.9)
lens. The nuclear intensities of fluorescence signals were quantified
using NIS-elements analysis software.
sgRNA-dCas system to label X-linked loci
To search the target microsatellite repeats for dCas9-GFP-mediated
genome visualisation, we first enumerated the sequences of N20GG
and N21GG whose specificities in a chromosome are greater than 19.
The specificity of a sequence s in chromosome c is defined to be the
ratio f cðsÞ=1þ∑i≠c f iðsÞ, where fc(s) denotes the frequency of s in c.
Since this entails that sequences appearing less than 20 times in all
chromosomes are irrelevant, we employed the k-mer counting
software DSK (version 2.1.0; (Rizk et al, 2013)) to obtain a list of
22- and 23-mers with a copy number > 19 on a chromosome. These
sequences and their complementary sequences were used as inputs to
the alignment software Bowtie (version 1.1.2; (Langmead et al, 2009))
against the FASTA files (GRCm38, Ensembl 84). We next searched
for candidate sequences enriched > 19 times in less than 1 Mb. Let
R be a region in c, then the frequency of s in R is fc(s) − nR(s) for
some integer nR(s). Therefore, the condition that the specificity of s
in R being > 19 results in nRðsÞ ≤ f cðsÞ20∑i≠c f iðsÞ20
 
=21. For
sequence s that satisfied the criteria, a comprehensive search for
connected regions of lengths less than 1 Mb containing fc(s) − nR(s)
alignments of s were performed on its Bowtie alignment output.
Among the candidates, 32 sequences were experimentally screened.
The expression vectors for sgRNA and dCas9-EGFP were
constructed using those obtained from Yolanda Markaki and Heinrich
Leonhardt (Anton et al, 2014). pex-A-U6p-sgRNA(F + E)-BbsI was
first generated from pEX-A-U6-sgRNA-antiMiS, which contained
microsatellite-specific sequence, to clone X-linked sgRNA into the BbsI
site. Oligonucleotides consisting of the target sequence and BbsI sites
were synthesised (Hokkaido System Science; Table EV1) and
annealed to insert into the linearised pex-A-U6p-sgRNA(F + E)-BbsI.
Each of the resulting plasmids was cotransfected with dCas9-EGFP
expression vector into MC12 cells grown on a 24-well glass bottom
plate (IWAKI) using Lipofectamine 2000 (Thermo Fisher Scientific),
according to the manufacturer’s instruction. Among 32 sgRNA
screened, 7 that exhibited distinct spots by transient expression (Table
EV1) were subcloned into a PiggyBac vector PB510B-1 (System BioS-
ciences) to establish stable lines. dCas9-EGFP was also subcloned into
another PiggyBac vector PB533-A2 (System BioSciences). The result-
ing PB510B-based sgRNA expression vector and PB533-dCas9-EGFP
were cotransfected with a transposase expression vector PB200PA-1
(System BioSciences) into MC12 cells, and stable clones were selected
in 1 mg/ml G418 and 1 μg/ml puromycin.
The selected MC12 cell lines were plated on a 35-mm glass
bottom dish (IWAKI) and fixed with 4% formaldehyde (Electron
Microscopy Sciences) in 250 mM HEPES-NaOH (pH 7.4; Wako Pure-
chemicals) containing 0.1% Triton X-100 for 5 min at room temper-
ature. Fixed cells were permeabilised with 1% Triton X-100 in PBS
for 20 min at room temperature and washed three times with PBS.
The cells were incubated with 2 μg/ml Cy5-conjugated anti-
H3K27me3 (CMA323/1E7; Hayashi-Takanaka et al, 2011) and 1 μg/
ml Hoechst33342 in 10% Blocking One-P (Nacalai Tesque) in PBS
for 1 h at room temperature. After washing three times with PBS,
fluorescence images were sequentially collected using a confocal
microscope (Nikon Ti-E with Yokogawa CSU-W1 spinning disk and
Andor iXon3 EM-CCD).
To obtain mitotic cells, MC12 cells were plated on 35-mm glass
bottom dish (IWAKI) and treated with colcemid (Nacalai Tesque) at
a final concentration of 50 ng/ml in the medium for 90 min. After
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removal of the medium, 75 mM KCl was added to the dish and incu-
bated for 30–40 min at room temperature to swell the cells. The
mitotic cells were fixed with 250 mM HEPES-NaOH (pH 7.4; Wako
Purechemicals) for 5 min at room temperature and permeabilised
with 0.1% Triton X-100 in PBS for 20 min at room temperature.
After washing with PBS, cells were stained with Cy5-conjugated
anti-H3K27me3 and Hoechst33342, as described above.
To visualise X-linked loci simultaneously with H3K27me3 or
H4K20me1 during X inactivation, female mESC lines expressing the
two sgRNA (mX8 and mX26), 3×sfGFP-dCas9 and H3K27me3-mint-
body (SNAP-Tag version, visualised with JF646 (Grimm et al,
2015) and H4K20me1-mintbody (mCherry version) were estab-
lished. For tracking differentiating mouse ESCs in 3D over several
hours, we used mintbodies tagged with nuclear localisation signals
to increase the brightness in nuclei. Therefore, the oscillation of the
global modification levels throughout the cell cycle was not moni-
tored (Rice et al, 2002). PGK12.1 mouse female ES cells (Penny
et al, 1996) were routinely grown on dish coated with 0.1% gelatin
(Wako Purechemicals) in DMEM high glucose (Nacalai Tesque)
with 10% FBS (Thermo Fisher Scientific), 1% L-Glutamine–Peni-
cillin–Streptomycin Solution (Sigma-Aldrich), 1% MEM non-essen-
tial amino acid solution (Nacalai Tesque), 1 mM Sodium Pyruvate
(Thermo Fisher Scientific), 55 µM 2-mercaptoethanol (Thermo
Fisher Scientific), 103 units/ml leukaemia inhibitory factor (LIF;
Nacalai Tesque) at 37°C and 5% CO2 atmosphere. PGK12.1 cells
were transfected with the expression vectors using Lipofectamine
2000 (Thermo Fisher Scientific) and selected in 1 mg/ml G418 and
1 μg/ml puromycin to obtain stable cell lines. To induce differentia-
tion, cells were plated at 1–2 × 104 cells per 10 cm dish and incu-
bated with LIF-free medium. For live imaging, mESCs were plated
on 35-mm μ-Dish (ibidi) coated with laminin (BioLamina) in Fluor-
oBrite DMEM (Thermo Fisher Scientific) containing all the other
supplements described above. The fluorescence images were
sequentially collected using a confocal system (Nikon Ti-E with
Yokogawa CSU-W1 spinning disk and Andor iXon3 EM-CCD) with
a heated stage (Tokai Hit) to maintain cells at 37°C under 5% CO2
atmosphere.
TX-based ESC lines
TX1072 [mouse, female, (Mus musculus castaneus X C57BL/6)
embryonic stem cells] cells have been previously derived in the lab
(Schulz et al, 2014). TX-BglSL cell line has been previously derived
from TX1072 (Dossin et al, 2020). TX-Xist-EGFP was established by
targeting a BglG-EGFP expression cassette into the ROSA26 permis-
sive locus. This was done by simultaneously transfecting TX-BglSL
ESCs with a targeting vector (ROSA26 homology arms, CAGS
promoter and BglG-EGFP-NLS fusion gene) and two pX330 plasmids
containing two sgRNAs to ROSA26 (TGGGCGGGAGTCTTCTGGGC
and ACTGGAGTTGCAGATCACGA). TX-Xist-mCherry cell line was
derived by targeting BglG-mCherry expression cassette into the
TIGRE permissive locus. This was done by simultaneously transfect-
ing TX-BglSL ESCs with a targeting vector (TIGRE homology arms,
CAGS promoter and BglG-mCherry-NLS fusion gene) and a single
pX459 plasmids containing an sgRNA to TIGRE (ACTGCCATAA-
CACCTAACTT). After brief puromycin selection, clones were picked
and screened by imaging. Subsequently, clones with heterozygous
insertion of the BglG cassette were selected by genotyping PCR. The
TX-Xist-EGFP; H4K20me1-mCherry cell line was derived by cotrans-
fecting TX-Xist-EGFP with pBaso transposase vector and a PiggyBac
vector harbouring an expression cassette for H4K20me1 mintbody
(15F11-mCherry) (Sato et al, 2016). The TX-Xist-mCherry;
H3K27me3-sfGFP cell line was derived by cotransfecting TX-Xist-
mCherry with pBaso transposase vector and a PiggyBac vector
harbouring an expression cassette for H3K27me3 mintbody (2E12LI-
sfGFP). All TX1072-based ESC lines were cultured on gelatine-
coated plates in Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 15% foetal bovine serum, 2-mercaptoethanol
(0.1 mM), LIF (1,000 U/ml) and 2i (PD0325901 [0.4 mM],
CHIR99021 [3 mM]). Cells were incubated at 37°C with 8% CO2.
TXY:XistFL (mouse, male embryonic stem cells) were obtained
from the Wutz team (Wutz et al, 2002), and TXY:XistΔBC was previ-
ously derived in the laboratory (Bousard et al, 2019). These lines
were cultured on gelatine-coated plates in Dulbecco’s Modified
Eagle Medium (DMEM) supplemented with 15% foetal bovine
serum, 2-mercaptoethanol (50 mM) and LIF (1,000 U/ml). Cells
were incubated at 37°C with 8% CO2.
DOX treatment
For TX1072-based ESC lines after 24 h of culture in DMEM/15%
FCS + LIF + 2i, the medium was supplemented with doxycycline
(1 μg/ml). For TXY-based ESC lines after 24 h of culture in DMEM/
15%FCS + LIF, cells were washed twice with PBS and medium was
changed to DMEM/10%FCS-LIF with doxycycline (1.5 μg/ml). Cells
were collected after 48 h of differentiation.
Antibody validation
H3K27me3 mintbody and H4K20me1 antibody used for nChIP-seq
(Active Motif cat. 39727) were validated for sensitivity and speci-
ficity using the MODified Histone Peptide Array (ActiveMotif)
following manufacturer’s instructions.
Native ChIP-seq
Native ChIP-seq was performed as previously described (Zylicz
et al, 2019). Cells were collected using Accutase (Thermo Fisher
Scientific), washed twice in ice-cold PBS and counted. Typically,
10 million (mln) cells were used per immunoprecipitation (IP). A
fraction of cells was always used for RNA/FISH verification of Xist
induction. Cell pellet was resuspended in 90 μl (per 10 mln cells) of
Lysis Buffer (50 mM Tris–HCl, pH 7.5; 150 mM NaCl; 0.1% sodium
deoxycholate; 1% Triton X-100; 5 mM CaCl2; Protease Inhibitor
Cocktail (Roche); 5 mM sodium butyrate). After lysing cells on ice
for 10 min, we added 62 μl (per 10 mln cells) of Lysis Buffer with
MNase (500 μl buffer + 0.5 μl MNase). Chromatin was digested for
exactly 8 min at 37°C, and reaction was stopped by the addition of
20 mM EGTA. To remove undigested debris, the lysates were centri-
fuged at 14,000 g for 5 min at 4°C. Supernatant was transferred to a
fresh tube, an equal volume of STOP Buffer (50 mM Tris–HCl,
pH 7.5; 150 mM NaCl; 0.1% sodium deoxycholate; 1% Triton X-
100; 30 mM EGTA; 30 mM EDTA; Protease Inhibitor Cocktail;
5 mM sodium butyrate) was added, and samples were stored on ice.
For the nChIP input, 5 μl of lysate was digested in 45 μl of ProtK
Digestion Buffer (20 mM HEPES; 1 mM EDTA; 0.5% SDS, 0.8 mg/
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ml Proteinase K) for 30 min at 56°C. 50 μl of AMPure XP beads were
added to the digested lysate together with 60 μl of 20% PEG8000
1.25 M NaCl. After mixing, the samples were incubated for 15 min
at RT. Beads were separated on a magnet and washed twice with
80% ethanol for 30 s. DNA was eluted in 12 μl of Low-EDTA TE.
DNA isolated in this step was used as the input sample. The volume
of each undigested lysate was adjusted to obtain 1 ml per IP using a
1:1 mix of Lysis Buffer and STOP Buffer. Anti-mouse Dynabeads
(25 μl/IP) were washed twice in Blocking Buffer (0.5% BSA; 0.5%
Tween in PBS). Beads were then resuspended in Blocking buffer
and coated with antibodies for 4 h at 4°C [H4K20me1 (0.5 μg/IP),
Active Motif cat. 39727]. Once coated beads were magnet-separated
and resuspended in 1 ml of lysate, samples were left rotating over-
night at 4°C. Following day, beads were magnet-separated and
washed quickly with ice-cold washing buffers: four times with Low
Salt Buffer, two times with High Salt Buffer (0.1% SDS; 1% Triton
X-100; 2 mM EDTA; 20 mM Tris–HCl, pH 8.1; 360 mM NaCl; 0.1%
sodium deoxycholate) and two times with LiCl buffer (0.25 M LiCl;
1% NP40; 1.1% sodium deoxycholate; 1 mM EDTA; 10 mM Tris–-
HCl pH 8.1). Prior to elution, all samples were rinsed once in TE.
ChIP-DNA was eluted in ProtK Digestion buffer for 15 min at 56°C.
Beads were separated, and the supernatant was further digested for
another 2 h at 56°C. DNA was isolated using AMPure XP beads as
described for the input sample.
For each nChIP-seq, 0.5 μl of each sample was used for qPCR
validation of enrichment at control regions. 0.5 μl of input samples
were also used to verify the digestion efficiency using D1000 tapes-
tation. Remaining DNA concentration was adjusted and used for
library preparation using Ovation® Ultralow Library System V2
following suppliers protocol. Amplified libraries were size-selected
for dinucleotide fraction (350–600 bp fragments) using agarose gel-
separation and MinElute Gel Extraction Kit (QIAGEN). Sample qual-
ity was inspected using D1000 tapestation. Samples were sequenced
using a HiSeq2500 with Paired-End (PE) 100 or a HiSeq4000 PE150.
nChIP-seq data processing
Adapters and low quality bases (< Q20) have been removed with
TrimGalore (v0.4.4; http://www.bioinformatics.babraham.ac.uk/
projects/trim_galore) and Cutadapt (1.12) (Martin, 2011). More-
over, for PE150 samples, last 50 pb were trimmed to allow unbiased
comparison of the data with PE100 samples. An “N-masked”
genome has been generated with SNPSplit (0.3.2) (Krueger &
Andrews, 2016) which is a version of the mouse reference genome
mm10 where all the polymorphic sites for the hybrid strain Mus
musculus CAST/EiJ and Mus musculus C57BL/6 are masked by
ambiguity nucleobase “N”. For all samples, reads were then mapped
to the “N-masked” genome with STAR (2.5.3a) with options [--
outFilterMultimapNmax 1 --outSAMmultNmax 1 --outFilterMis-
matchNmax 999 --outFilterMismatchNoverLmax 0.03 --alignIn-
tronMax 1 --alignEndsType EndToEnd --outSAMattributes NH HI
NM MD] (Dobin et al, 2013). Duplicates were discarded with Picard
MarkDuplicates (1.65) with options [REMOVE_DUPLICATES=true]
(https://broadinstitute.github.io/picard/) and reads mapped on
blacklisted regions from Encode Consortium were discarded.
SNPSplit (0.3.2) (Krueger & Andrews, 2016) was then used to gener-
ate allele-specific BAM files by separating the alignment into two
distinct alleles (CAST and B6) based on SNPs information
downloaded from Sanger. Bigwig files were created with bedtools
genome CoverageBed (2.27.1) (Quinlan & Hall, 2010), using a scale
factor calculated on the total library (10,000,000/total reads) for
both allele-specific bigwigs, and loaded on UCSC genome browser.
H3K27me3 nChIP-seq data were downloaded from GSE116990 and
processed identically to H4K20me1 nChIP-seq.
Windows definition
Global analysis was first done on fixed windows (10 kb) spanning
the whole genome and then on different genomic subcategories:
initially active genes, silent genes and intergenic regions. Initially
active genes were defined as genes with a transcript having its TSS
(refFlat annotation) overlapping a consensus peak of H3K9ac and a
consensus peak of H3K4me3. Moreover, initially active genes were
filtered to remove potentially bivalent genes by discarding genes
with a normalised H3K27me3 signal superior to 0.035 at t0, value
defined from the intersection of density curves of H3K27me3
premarking signal of genes initially defined as active and inactive.
For genes having several active transcripts detected, the active gene
was defined as starting at the minimum start of transcripts and
ending at the maximum end of transcripts. Moreover, using RNA-
seq data (Zylicz et al, 2019), genes having a mean TPM (2
samples) < 1 at t0 were excluded from this list. Silent genes were
defined as genes with TSS not overlapping a consensus peak of
H3K9ac and a consensus peak of H3K4me3. Using RNA-seq data
(ref), genes having a mean TPM > 1 at t0 were excluded from this
list. Intergenic regions were defined as 10 kb windows not overlap-
ping a gene (active or inactive) and its promoter (2 kb upstream) or
an active enhancer (defined in Zylicz et al, 2019).
Counts and normalisation
For all defined windows, total and allelic reads overlapping those
features were then counted using featureCounts (1.5.1), with
options [-C -p -P] (Liao et al, 2014). Then, analysis was done based
on normalised reads from B6 allele (allele of the inactive X chro-
mosome). For each sample, a normalisation factor was calculated
with the trimmed mean of M-values method (TMM) from edgeR
package (Robinson et al, 2010), based on B6 reads overlapping
consensus peaks located on autosomes. Peaks of each sample were
first identified using MACS2 (2.0.10) with -B --broad options. For
each replicate, all peaks coordinates were merged using bedtools
merge (2.27.1) (Quinlan & Hall, 2010). Then, common regions
between merged peaks coordinates of each replicate were selected
using bedtools intersectBed (2.27.1) (Quinlan & Hall, 2010) to
represent B6 read accumulation compared to time 0, subtraction of
normalised initial counts (time 0) was then applied to all other
time points.
Analysis of the dynamics
Sigmoidal fitting of B6 read accumulation in function of time has
also been done with the four-parameter log-logistic function from
drc R package. Sigmoidal fittings with low residuals (< mean(resid-
uals) + 1.5 sd(residuals)) were selected. The ED50 of the sigmoidal
fitting were calculated for each window. Windows with ED50 deriva-
tive superior to 24 h, or not calculated, were considered as windows
with a late accumulation of repressive marks, those were then
replaced by 24 h. For pairwise comparison between marks, only
windows with ED50 inferior to 24 h for both marks were selected.
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Average plots over features
Average plots were created around initially active and silent genes
using DeepTools (3.0.2) (Ramirez et al, 2014). Matrix counts were
created using DeepTools computeMatrix around genes (see above)
on chrX and autosomes separately (with option [--binSize 500]),
and plots were then created using DeepTools PlotProfile.
Average plots were created with same method around early and
late silenced genes. Those genes were defined with a three clusters
k-means based on IC35 values calculated after sigmoidal fitting of
TT-seq data such as described in (Zylicz et al, 2019), defining early,
intermediate and late silenced genes.
IF/RNA FISH
IF/RNA FISH experiments were performed as previously (Bousard
et al, 2019). Xist FL and mutant ES cells were differentiated for 48 h in
the presence of DOX (1.5 μg/ml) on gelatine-coated 22 × 22 mm
coverslips. Cells were fixed in 3% PFA in PBS for 10 min at RT,
followed by permeabilisation in PBS containing 0.5% Triton X-100
and ribonucleoside-vanadyl complex (New England Biolabs) on ice
for 5 min. After three rapid washes in PBS, samples were blocked for,
at least, 15 min with 5% gelatine from cold water fish skin (Sigma) in
PBS. Coverslips were incubated with the H4K20me1 primary antibody
(Abcam, abb9051) diluted in blocking solution in the presence of a
ribonuclease inhibitor (0.8 μl/ml; Euromedex) for 45 min at RT. After
three washes with PBS for 5 min, the coverslips were incubated with
a secondary antibody (anti-rabbit antibodies conjugated with Alexa
fluorophores diluted 1:500) for 45 min in blocking solution supple-
mented with ribonuclease inhibitor (0.8 μl/ml; Euromedex). Cover-
slips were then washed three times with PBS for 5 min at RT.
Afterwards, cells were post-fixed with 3% PFA in PBS for 10 min at
RT and rinsed three times in PBS and twice in 2 × SSC. Excess of
2 × SSC was removed, and cells were hybridised with a Xist p510
probe labelled with Alexa labelled dUTPs. After the RNA FISH proce-
dure, nuclei were stained with DAPI (Sigma-Aldrich), diluted 1:5,000
in 2 × SCC for 5 min at RT and mounted with Vectashield Mounting
Medium (Vectorlabs). Cells were imaged with a widefield fluorescence
microscope Zeiss Axio Observer (Carl Zeiss MicroImaging) with a 63×
oil objective using the filter sets FS43HE, FS38HE, FS50 and FS49.
Digital images were analysed with the FIJI platform (https://fiji.sc/).
Enrichment of the H4K20me1 signals over Xist cloud marked by RNA
FISH was counted from at least 50 cells per single experiment.
RNA extraction, reverse transcription, pyrosequencing
RNA was extracted according to the manufacturer’s recommenda-
tions using RNeasy Mini Kit (QIAGEN) with on-column DNase
digestion (QIAGEN). For cDNA synthesis 1.1 μg RNA was reverse-
transcribed using Superscript III Reverse Transcriptase (Thermo
Fisher Scientific). For allelic-skewing analysis, the cDNA was PCR-
amplified with biotinylated primers and sequenced using the Pyro-
mark Q24 system (QIAGEN).
Live-cell imaging of TX1072-based ESC lines
For all TX1072-based ESC lines one day before imaging, 30,000 cells
were seeded in a fibronectin coated μ-Slide 8 well with glass bottom
(Ibidi) in 300 μl medium. To induce Xist expression, doxycycline
was added to medium 5 min before imaging. Live-cell imaging was
performed on an inverted spinning disk confocal microscope Roper/
Nikon using a Evolve EM-CCD camera (Photometrics) with a 60×
oil objective. Images were taken every 15 min for 10 h with Z slices
with 400-nm intervals. During imaging, cells were kept in a cham-
ber at 37°C and 5% CO2.
Quantification of mintbody accumulation was performed using Icy
Version 1.9.8.1 and ImageJ. Quantification was done on maximum
projections of z-planes. The TX-Xist-EGFP or TX-Xist-mCherry channel
was segmented into an Xist-enriched region to separate the Xi from the
rest of the nucleus. This region was then applied to the mintbody chan-
nel, and mean intensity of the signal was measured per time point. To
normalise for the background signal in the nucleus, every 10 time
points the signal in the same nucleus was measured using ImageJ. This
was used to calculate the background for every time point. The value
of signal in the cloud was then divided by this background.
Data availability
The accession number for the sequencing datasets reported in this
paper is GEO: GSE153146 (http://www.ncbi.nlm.nih.gov/geo/que
ry/acc.cgi?acc=GSE153146). Nucleotide sequence data of 2E12LI
scFv are available in several public databases (DDBJ/EMBL/
GenBank) under the accession number LC597262.
Expanded View for this article is available online.
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